Asthma and obesity in children: current evidence and potential systems biology approaches

U Frey1, P Latzin, J Usemann

  • 1University Children's Hospital Basel, UKBB, Basel, Switzerland.

Allergy
|September 20, 2014
PubMed

Insights

Obesity and asthma in children share complex causes, but effective treatments are lacking. This review explores factors and research hypotheses for treating obese children with asthma.

Area of Science:

  • Pediatric Pulmonology
  • Pediatric Endocrinology
  • Immunology

Background:

  • Obesity and asthma are prevalent childhood diseases with complex, multifactorial origins.
  • The mechanistic interactions between childhood obesity and asthma are poorly understood, with limited evidence of causality.
  • Effective treatment strategies for obese children with asthma are scarce, despite potential long-term health impacts.

Purpose of the Study:

  • To review current evidence on the investigation and treatment of asthma in obese children.
  • To compare approaches for obese asthmatic children with those for difficult-to-treat childhood asthma.
  • To propose future research directions from a systems-based perspective.

Main Methods:

  • Literature review of genetic, developmental, immunological, mechanical, and behavioral factors.
  • Analysis of existing data on childhood asthma and obesity.
  • Synthesis of evidence for clinical management and research hypotheses.

Main Results:

  • Multiple factors contribute to the obesity-asthma link in children, but causality remains unclear.
  • Current treatment strategies for obese asthmatic children are not well-defined.
  • Significant gaps exist in understanding the interplay between obesity and asthma in pediatric populations.

Conclusions:

  • Further research is needed to elucidate the complex mechanisms underlying childhood obesity and asthma.
  • Developing targeted and effective treatment strategies for obese children with asthma is a critical unmet need.
  • A systems-based approach is recommended for future research to address this complex comorbidity.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
69
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
35